Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence

Vaccines remain the cornerstone of medical prevention and are highly effective in reducing the risk of severe disease and death due to coronavirus disease 2019 (COVID-19). In the context of expanding the therapeutic armamentarium against COVID-19, molnupiravir (Lagevrio) and ritonavir-boosted nirmat...

Descripción completa

Detalles Bibliográficos
Autores principales: Karniadakis, Ioannis, Mazonakis, Nikolaos, Tsioutis, Constantinos, Papadakis, Michail, Markaki, Ioulia, Spernovasilis, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660858/
https://www.ncbi.nlm.nih.gov/pubmed/37987399
http://dx.doi.org/10.3390/idr15060061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660858/
https://www.ncbi.nlm.nih.gov/pubmed/37987399
http://dx.doi.org/10.3390/idr15060061

Ejemplares similares